BioLife Solutions swings to Q2 FY26 GAAP net income of $45.1 million; revenue rises 21% to $28.5 million vs Q2 FY25
PUBT · 3d ago
Share
Listen to the news
- BioLife Solutions posted Q2 2026 revenue of USD 28.5 million, up 21% from Q2 2025.
- GAAP operating income was USD 1.7 million, swinging from a GAAP operating loss a year earlier.
- GAAP net income was USD 45.1 million, returning to profit; results included a USD 42.4 million non-cash income tax benefit.
- Non-GAAP adjusted EBITDA rose to USD 7.4 million, equal to 26% of revenue.
- Repligen agreed to acquire BioLife for about USD 1.5 billion, with the deal expected to close in Q4 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioLife Solutions Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608061603PR_NEWS_USPR_____LA21201) on August 06, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending